About Glucoset
Glucoset is a company based in Trondheim (Norway) founded in 2013 was acquired by Televenture in April 2015.. Glucoset has raised $6.59 million across 8 funding rounds from investors including European Union, Norwegian Research Council and EIC Fund. The company has 20 employees as of December 31, 2022. Glucoset offers products and services including GlucoSet Sensor. Glucoset operates in a competitive market with competitors including Dexcom, Withings, Livongo, One Drop and Ultrahuman, among others.
- Headquarter Trondheim, Norway
- Employees 20 as on 31 Dec, 2022
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Glucoset As
-
Annual Revenue
$104.68 K (USD)374as on Dec 31, 2021
-
Net Profit
$-601.85 K (USD)-131as on Dec 31, 2022
-
EBITDA
$-474.9 K (USD)-170as on Dec 31, 2022
-
Total Equity Funding
$6.59 M (USD)
in 8 rounds
-
Latest Funding Round
$6.52 M (USD), Series A
Jul 07, 2023
-
Investors
European Union
& 4 more
-
Employee Count
20
as on Dec 31, 2022
-
Acquired by
Televenture
(Apr 09, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Glucoset
Glucoset offers a comprehensive portfolio of products and services, including GlucoSet Sensor. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Minimally invasive sensor for continuous blood glucose monitoring in ICU
Funding Insights of Glucoset
Glucoset has successfully raised a total of $6.59M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $6.52 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $6.5M
-
First Round
First Round
(01 Jun 2016)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Grant - Glucoset | Valuation |
investors |
|
| Jul, 2023 | Amount | Series A - Glucoset | Valuation | Swiss Diabetes Venture Fund |
|
| Nov, 2020 | Amount | Grant - Glucoset | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Glucoset
Glucoset has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Norwegian Research Council and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Investments are focused on diabetes technology startups worldwide.
|
Founded Year | Domain | Location | |
|
Televenture is recognized as a leading venture capital firm in Norway.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Glucoset
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Glucoset
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glucoset Comparisons
Competitors of Glucoset
Glucoset operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Withings, Livongo, One Drop and Ultrahuman, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| domain | founded_year | HQ Location |
Connected devices for health, sleep, and activity monitoring are developed.
|
|
| domain | founded_year | HQ Location |
Provider of smart devices for diabetes management for patients and doctors
|
|
| domain | founded_year | HQ Location |
Provider of workforce healthcare solutions
|
|
| domain | founded_year | HQ Location |
Metabolic health is tracked via devices and fitness platforms.
|
|
| domain | founded_year | HQ Location |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Glucoset
When was Glucoset founded?
Glucoset was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Where is Glucoset located?
Glucoset is headquartered in Trondheim, Norway. It is registered at Trondheim, Trøndelag, Norway.
Is Glucoset a funded company?
Glucoset is a funded company, having raised a total of $6.59M across 8 funding rounds to date. The company's 1st funding round was a Grant of $59.81K, raised on Jun 01, 2016.
How many employees does Glucoset have?
As of Dec 31, 2022, the latest employee count at Glucoset is 20.
What is the annual revenue of Glucoset?
Annual revenue of Glucoset is $104.68K as on Dec 31, 2021.
What does Glucoset do?
Glucoset was founded in 2013 in Trondheim, Norway, and operates in the medical devices sector. Intravascular sensors for continuous blood glucose monitoring are produced, allowing access through existing arterial catheters without additional insertions or equipment displacement. Glucose levels are tracked in real time for patients, supporting level normalization. The sensors are designed for compatibility with patient movement and reduced cross-sectional area relative to alternatives.
Who are the top competitors of Glucoset?
Glucoset's top competitors include Withings, Ultrahuman and Oura.
What products or services does Glucoset offer?
Glucoset offers GlucoSet Sensor.
Who are Glucoset's investors?
Glucoset has 5 investors. Key investors include European Union, Norwegian Research Council, EIC Fund, Diabetes Venture Fund, and Televenture.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.